ESLAEstrella Immunopharma, Inc.
- Market cap
- $42.85M
- as of 2026-10-23
- Latest close
- $0.99
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-05
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Liu ChengCEO | Aug 25 | Aug 26 | M | 100,000 | $0.82 | $82,000 | 397,437 | No | Form 4 |
| Liu ChengCEO | Aug 25 | Aug 26 | M · derivative | 100,000 | $0.82 | $82,000 | 900,000 | No | Form 4 |
| Xu JiandongChief Financial Officer | Aug 18 | Aug 25 | M | 100,000 | $0.82 | $82,000 | 365,488 | No | Form 4 |
| Xu JiandongChief Financial Officer | Aug 18 | Aug 25 | M · derivative | 100,000 | $0.82 | $82,000 | 390,796 | No | Form 4 |
| Xu JiandongChief Financial Officer | Oct 7, 2025 | Apr 29 | P | 1,000 | $1.33 | Purchase +$1,330 | 265,488 | No | Form 4 |
| Xu JiandongChief Financial Officer | Sep 22, 2025 | Apr 29 | P | 1,000 | $1.16 | Purchase +$1,160 | 16,700 | No | Form 4 |
| Xu JiandongChief Financial Officer | Sep 11, 2025 | Apr 29 | P | 100 | $1.04 | Purchase +$104 | 264,588 | No | Form 4 |
| Xu JiandongChief Financial Officer | Oct 30, 2024 | Feb 14, 2025 | A · derivative | 490,796 | $0.82 | $402,453 | 490,796 | No | Form 4 |
| Xu JiandongChief Financial Officer | Oct 30, 2024 | Feb 14, 2025 | A · derivative | 509,204 | $0.82 | $417,547 | 509,203 | No | Form 4 |
| Liu ChengChief Executive Officer | Oct 30, 2024 | Feb 14, 2025 | A · derivative | 490,796 | $0.82 | $402,453 | 490,796 | No | Form 4 |
| Liu ChengChief Executive Officer | Oct 30, 2024 | Feb 14, 2025 | A · derivative | 509,204 | $0.82 | $417,547 | 509,203 | No | Form 4 |
| Altman Jeffrey A | Sep 29, 2023 | Oct 5, 2023 | J | 255,000 | $10.86 | $2,769,300 | not reported | No | Form 4 |